11/09/2026
Linklaters advises Zylox-Tonbridge on acquisition of equity interest in LifeTech Scientific Corporation and new share issuance
Upon completion of the transactions, Zylox-Tonbridge will indirectly hold approximately 16.7% of the voting rights in LifeTech and an effective interest of approximately 10%.